Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

W Raymond Cohen

Affiliations

  • Chief Executive Officer at Axonics Modulation Technologies Inc. (AXNX), 2020-01-16
  • Director at Biolife Solutions Inc (BLFS), 2019-08-20
  • Director at Spectrum Pharmaceuticals Inc (SPPI), 2019-06-22
  • Director at Cardiogenesis Corp (CGCP.PK), 2011-05-17
  • Director at Cardiac Science Corp (CSCX), 2009-05-27
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AXNX $30.41 3,500 683,391 2019-08-06 Filing
BLFS $2.48 1,250 Director, Other 8,466 2014-08-08 Filing
BLFS $2.39 4,000 Director, Other 7,216 2014-05-20 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
AXNX $31.98 10,000 608,391 2020-01-13 Filing
AXNX $20.74 75,000 608,391 2019-11-19 Filing
BLFS $17.98 5,357 Director 23,388 2019-08-15 Filing
BLFS $16.57 5,357 Director 23,388 2019-07-15 Filing
BLFS $17.48 5,357 Director 23,388 2019-06-17 Filing